Valuation: Zai Lab Limited

Market Cap 2.97B 2.61B 2.45B 2.24B 4.18B 284B 4.22B 29.42B 11.4B 145B 11.15B 10.9B 470B P/E 2026 *
-12x
P/E 2027 * -11.9x
Enterprise Value 2.51B 2.2B 2.07B 1.89B 3.54B 241B 3.57B 24.88B 9.65B 123B 9.43B 9.22B 398B EV / Sales 2026 *
5.75x
EV / Sales 2027 * 4.69x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.11%
1 week+7.17%
Current month+3.85%
1 month+1.65%
3 months+43.00%
6 months+50.14%
Current year+49.89%
1 week 25.6
Extreme 25.6
27.14
1 month 23.64
Extreme 23.64
27.5
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
34.72
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
119.16
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 2014-03-31
Director of Finance/CFO 58 2023-07-06
President 62 2022-11-30
Director TitleAgeSince
Chairman 61 2014-03-31
Director/Board Member 83 2016-12-31
Director/Board Member 75 2016-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/19/26 Sell

Chief Financial Officer

-260 0.0000%
8/14/26 Exercice

Chief Financial Officer

2,927 0.0003%
8/12/26 Other

Director

-85,060 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+7.17%-17.56%+8.05% 2.96B
-0.26%+3.51%+41.19%-2.79% 80.27B
-0.25%+25.06%+606.13%+82.13% 72.88B
+0.12%+1.06%-9.07%-29.07% 61.51B
-1.80%-3.05%-14.24%+26.38% 47.39B
-0.89%+2.67%+3.52%+157.67% 46.58B
+0.96%+5.33%+63.33%-11.70% 33.3B
-1.80%-0.09%+47.43%+114.53% 25.73B
-3.00%+4.42%+5.63%+157.44% 22.88B
-1.92%+0.05%+57.90%+100.00% 15.82B
Average -0.95%+5.57%+78.43%+60.26% 40.93B
Weighted average by Cap. -0.82%+6.80%+123.95%+49.67%

Financials

2026 *2027 *
Net sales 436M 383M 360M 329M 615M 41.81B 620M 4.33B 1.68B 21.32B 1.64B 1.6B 69.11B 552M 485M 456M 416M 778M 52.89B 784M 5.47B 2.12B 26.96B 2.07B 2.03B 87.43B
Net income -241M -211M -199M -182M -339M -23.05B -342M -2.38B -925M -11.75B -904M -884M -38.11B -211M -185M -174M -159M -298M -20.22B -300M -2.09B -811M -10.31B -793M -775M -33.42B
Net Debt -458M -402M -378M -345M -645M -43.84B -650M -4.54B -1.76B -22.35B -1.72B -1.68B -72.47B -381M -334M -314M -287M -537M -36.48B -541M -3.77B -1.46B -18.6B -1.43B -1.4B -60.3B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
26-09-23 US$26.44 +0.11% 791,634
26-09-22 US$26.41 -0.08% 996,561
26-09-21 US$26.43 +2.84% 1,182,035
26-09-18 US$25.70 -0.43% 887,484
26-09-17 US$25.81 +4.62% 673,110
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
26.44USD
Average target price
33.14USD
Spread / Average Target
+25.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock